News
-
Bio21 Teams Funded for DiscoveryCongratulations to members of the Bio21 community whose research has received funding and who have been part of LIEF infrastructure and equipment grants that have received funding.
-
Why flu can be fatalAfter an initial severe infection, patients may be at high risk of contracting secondary infections and developing fatal pneumonia.
-
Coming to the genetic rescue of our endangered marsupialsGenetic variation is essential for survival; it allows species to adapt and evolve so they can overcome disease and other environmental threats, and avoid the negative consequences of inbreeding.
-
Bio21 researchers reap rewards at ComBio2107 conferenceBio21 researchers from the Department of Biochemistry and Molecular Biology, including the Tilley, van Driel, McConville, Gleeson and Hinde labs made a good showing, presenting their work and collecting awards for their presentations.
-
Prof Eric Reynolds receives Prime Minster's Prize for Innovation19 October 2017
-
Media Release: University of Melbourne and Telix Pharmaceuticals Establish Cancer Translational Research PartnershipNovel technology discovered at University of Melbourne has the potential to transform the management of cancer
-
Bio21 NHMRC Grants fund Asthma, Antimicrobial Resistance and Dental Research.Congratulations to Kat Holt, Spencer Williams and Eric Reynolds upon receiving NHMRC funding.
-
Research Scientist for a week - By Elvis TranFor a week in June, I was no longer a student bound by books and constantly in a classroom setting. Instead, I had become a research scientist at Bio21, surrounded by million-dollar cutting-edge biotechnology.
-
President of Croatia, Her Excellency Ms Kolinda Grabar-Kitarovic visits Bio21Today an MOU was signed between the University of Melbourne and the University of Zagreb to facilitate research collaboration and PhD pathways.
-
Media Release: Discovery-driven research leads to breakthrough in understanding rare Sengers syndromeBio21 Researcher, Dr Diana Stojanovski, has unlocked important information that could lead to improved treatment of a rare and serious genetic condition, Senger's Syndrome.
